Management of Ventilator-Associated Pneumonia

Guidelines

Mark L. Metersky, Andre C Kalil

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Two recent major guidelines on diagnosis and treatment of ventilator-associated pneumonia (VAP) recommend consideration of local antibiotic resistance patterns and individual patient risks for resistant pathogens when formulating an initial empiric antibiotic regimen. One recommends against invasive diagnostic techniques with quantitative cultures to determine the cause of VAP; the other recommends either invasive or noninvasive techniques. Both guidelines recommend short-course therapy be used for most patients with VAP. Although neither guideline recommends use of procalcitonin as an adjunct to clinical judgment when diagnosing VAP, they differ with respect to use of serial procalcitonin to shorten the length of antibiotic treatment.

Original languageEnglish (US)
Pages (from-to)797-808
Number of pages12
JournalClinics in Chest Medicine
Volume39
Issue number4
DOIs
StatePublished - Dec 1 2018

Fingerprint

Ventilator-Associated Pneumonia
Guidelines
Calcitonin
Anti-Bacterial Agents
Microbial Drug Resistance
Therapeutics

Keywords

  • Guideline
  • Hospital-acquired pneumonia
  • Nosocomial pneumonia
  • Ventilator-associated pneumonia

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Management of Ventilator-Associated Pneumonia : Guidelines. / Metersky, Mark L.; Kalil, Andre C.

In: Clinics in Chest Medicine, Vol. 39, No. 4, 01.12.2018, p. 797-808.

Research output: Contribution to journalReview article

@article{311dcb5114834feeb0c9b049505b28d9,
title = "Management of Ventilator-Associated Pneumonia: Guidelines",
abstract = "Two recent major guidelines on diagnosis and treatment of ventilator-associated pneumonia (VAP) recommend consideration of local antibiotic resistance patterns and individual patient risks for resistant pathogens when formulating an initial empiric antibiotic regimen. One recommends against invasive diagnostic techniques with quantitative cultures to determine the cause of VAP; the other recommends either invasive or noninvasive techniques. Both guidelines recommend short-course therapy be used for most patients with VAP. Although neither guideline recommends use of procalcitonin as an adjunct to clinical judgment when diagnosing VAP, they differ with respect to use of serial procalcitonin to shorten the length of antibiotic treatment.",
keywords = "Guideline, Hospital-acquired pneumonia, Nosocomial pneumonia, Ventilator-associated pneumonia",
author = "Metersky, {Mark L.} and Kalil, {Andre C}",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.ccm.2018.08.002",
language = "English (US)",
volume = "39",
pages = "797--808",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Management of Ventilator-Associated Pneumonia

T2 - Guidelines

AU - Metersky, Mark L.

AU - Kalil, Andre C

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Two recent major guidelines on diagnosis and treatment of ventilator-associated pneumonia (VAP) recommend consideration of local antibiotic resistance patterns and individual patient risks for resistant pathogens when formulating an initial empiric antibiotic regimen. One recommends against invasive diagnostic techniques with quantitative cultures to determine the cause of VAP; the other recommends either invasive or noninvasive techniques. Both guidelines recommend short-course therapy be used for most patients with VAP. Although neither guideline recommends use of procalcitonin as an adjunct to clinical judgment when diagnosing VAP, they differ with respect to use of serial procalcitonin to shorten the length of antibiotic treatment.

AB - Two recent major guidelines on diagnosis and treatment of ventilator-associated pneumonia (VAP) recommend consideration of local antibiotic resistance patterns and individual patient risks for resistant pathogens when formulating an initial empiric antibiotic regimen. One recommends against invasive diagnostic techniques with quantitative cultures to determine the cause of VAP; the other recommends either invasive or noninvasive techniques. Both guidelines recommend short-course therapy be used for most patients with VAP. Although neither guideline recommends use of procalcitonin as an adjunct to clinical judgment when diagnosing VAP, they differ with respect to use of serial procalcitonin to shorten the length of antibiotic treatment.

KW - Guideline

KW - Hospital-acquired pneumonia

KW - Nosocomial pneumonia

KW - Ventilator-associated pneumonia

UR - http://www.scopus.com/inward/record.url?scp=85055750452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055750452&partnerID=8YFLogxK

U2 - 10.1016/j.ccm.2018.08.002

DO - 10.1016/j.ccm.2018.08.002

M3 - Review article

VL - 39

SP - 797

EP - 808

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

IS - 4

ER -